Lawrence Klein

Lawrence Klein

Director/Board Member at JADE BIOSCIENCES, INC.

Net worth: 86 M $ as of 2026-08-30

43 year
Health Technology
Consumer Services
Finance

Profile

Lawrence O. Klein is on the board of Dyne Therapeutics, Inc. and Chief Operating & Business Officer at CRISPR Therapeutics AG. Dr. Klein previously occupied the position of Associate Partner at Mckinsey & Co. (Switzerland). Dr. Klein received a doctorate from Stanford University and an undergraduate degree from the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
1.39%
2026-09-14 923,128 ( 1.39% ) 86 M $ 2026-08-30
2026-06-08 70 ( 0% ) 1 495 $ 2026-08-30

Lawrence Klein active positions

CompaniesPositionStart
JADE BIOSCIENCES, INC. Director/Board Member 2025-04-27

Former positions of Lawrence Klein

CompaniesPositionEnd
Private Equity Investor 2024-01-31
JASPER THERAPEUTICS, INC. Director/Board Member 2023-06-19
DYNE THERAPEUTICS, INC. Director/Board Member 2023-05-23
CRISPR THERAPEUTICS AG Chief Operating Officer 2022-09-30
Corporate Officer/Principal 2016-01-31
See the detail of Lawrence Klein's experience

Training of Lawrence Klein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Consumer Services

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Lawrence Klein